ATE370729T1 - Stabile t3 zusammensetzungen und ihre anwendung - Google Patents

Stabile t3 zusammensetzungen und ihre anwendung

Info

Publication number
ATE370729T1
ATE370729T1 AT01272465T AT01272465T ATE370729T1 AT E370729 T1 ATE370729 T1 AT E370729T1 AT 01272465 T AT01272465 T AT 01272465T AT 01272465 T AT01272465 T AT 01272465T AT E370729 T1 ATE370729 T1 AT E370729T1
Authority
AT
Austria
Prior art keywords
stable
patient
compositions
application
cardiac
Prior art date
Application number
AT01272465T
Other languages
English (en)
Inventor
Irwin Klein
Kaie Ojamaa
Leo Rubin
Original Assignee
Resuscitation Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resuscitation Technologies Llc filed Critical Resuscitation Technologies Llc
Application granted granted Critical
Publication of ATE370729T1 publication Critical patent/ATE370729T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01272465T 2000-12-21 2001-11-30 Stabile t3 zusammensetzungen und ihre anwendung ATE370729T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25766600P 2000-12-21 2000-12-21
US79825901A 2001-03-12 2001-03-12
US32756901P 2001-03-12 2001-03-12
PCT/US2001/044855 WO2002051403A1 (en) 2000-12-21 2001-11-30 Compositions of stable t3 and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE370729T1 true ATE370729T1 (de) 2007-09-15

Family

ID=26946117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01272465T ATE370729T1 (de) 2000-12-21 2001-11-30 Stabile t3 zusammensetzungen und ihre anwendung

Country Status (7)

Country Link
EP (1) EP1351673B1 (de)
JP (3) JP2004525874A (de)
AT (1) ATE370729T1 (de)
CA (1) CA2432523C (de)
DE (1) DE60130145T2 (de)
ES (1) ES2291274T3 (de)
WO (1) WO2002051403A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3908272T3 (fi) * 2019-01-09 2023-04-25 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A L-trijodityroniini (T3) käytettäväksi mikrovaskulaarisen obstruktion rajoittamisessa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006457A1 (fr) * 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Composition medicinale contenant de l'albumine en tant que support et procede de preparation
DE4226949A1 (de) * 1992-08-14 1994-02-17 Boehringer Mannheim Gmbh Verfahren und Standardlösung zur Bestimmung von Thyroxin (T¶4¶) oder Trijodthyronin (T¶3¶)
DE3812609A1 (de) * 1988-04-15 1989-11-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung von thyroxin und dazu geeignete standardloesung
GB2240474B (en) * 1990-02-05 1994-01-12 British Tech Group Thyroid hormone cardiac treatment
JP3895782B2 (ja) * 1992-10-26 2007-03-22 生化学工業株式会社 コンドロイチナーゼ組成物およびそれを含有する注射用製剤
JP2622653B2 (ja) * 1992-12-18 1997-06-18 三洋化成工業株式会社 甲状腺ホルモン水溶液
JPH06213598A (ja) * 1993-01-19 1994-08-02 Mitsubishi Electric Corp 誘導飛翔体
JP3428225B2 (ja) * 1995-04-28 2003-07-22 三菱ウェルファーマ株式会社 ポルフィリン金属錯体−アルブミン包接化合物及び酸素運搬体
US5795789A (en) * 1997-06-04 1998-08-18 Dade Behring Inc. Standard solution for the determination of thyroid function
CN1299285A (zh) * 1998-05-29 2001-06-13 拜奥根有限公司 重组人干扰素β－1A(IFN－β－1A)制剂

Also Published As

Publication number Publication date
JP2005060409A (ja) 2005-03-10
CA2432523A1 (en) 2002-07-04
CA2432523C (en) 2014-06-03
EP1351673A1 (de) 2003-10-15
DE60130145D1 (de) 2007-10-04
DE60130145T2 (de) 2008-05-15
WO2002051403A1 (en) 2002-07-04
JP2009120625A (ja) 2009-06-04
EP1351673B1 (de) 2007-08-22
ES2291274T3 (es) 2008-03-01
JP2004525874A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
ATE311750T1 (de) Antibakterielle mittel sowie diese enthaltende antibakterielle und deodorierende lösung
ATE289332T1 (de) Silikongel enthaltend salizylsäure
TR200001203T2 (tr) Yeni birleşik maddeler
DE69521623D1 (de) Zusammensetzung für die stabilisation von zahnprothesen
ATE270111T1 (de) Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
DK0801554T3 (da) Formuleringer og fremgangsmåder til reduktion af hudirritation
BR0113751A (pt) Composições cosméticas e farmacêuticas e seus empregos
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
PT1216707E (pt) Novas utilizacoes terapeuticas para um smr-1-peptideo
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
ATE290396T1 (de) Neue verwendung von hypoosmotischen salinelösungen und darauf basierendem medikament
BR9914644A (pt) Composições tamponadas para diálise
SE9801494D0 (sv) Novel use
ATE370729T1 (de) Stabile t3 zusammensetzungen und ihre anwendung
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
PT1333797E (pt) Composicoes dentarias para dentes hipersensiveis
BR0009194A (pt) Composição do resorcinol
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
ES2161913T3 (es) Complejos cationicos trinucleares de platino que tienen una actividad antitumoral y composiciones farmaceuticas que los contienen.
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
DK1450616T4 (da) Præparation af krydderurter
DE69906558D1 (de) Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties